Search

JP-2026076172-A - Oral intake products with reduced sugar content

JP2026076172AJP 2026076172 AJP2026076172 AJP 2026076172AJP-2026076172-A

Abstract

[Problem] To provide an orally ingestible product and composition that has a reduced sugar content and achieves the same or very similar taste quality as conventional products in terms of sweetness, overall taste, and aftertaste. [Solution] A product for oral intake, such as a food, comprising at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II, and at least one sugar selected from the group consisting of sucrose, glucose, and fructose, in a mass ratio of thaumatin to sugar of 1:2,000 to 1:80,000. [Selection Diagram] None

Inventors

  • ステファン アネット
  • ハーン－レーブマン シモーネ
  • プロハスカ ハイケ
  • ギリッチ アナトリ
  • グレバ ユリ

Assignees

  • ノマド バイオサイエンス ゲゼルシャフト ミット ベシュレンクテル ハフツング

Dates

Publication Date
20260511
Application Date
20251225
Priority Date
20200716

Claims (20)

  1. At least one thaumatin selected from the group consisting of thaumatin I and thaumatin II, and at least one sugar selected from the group consisting of sucrose, glucose, and fructose, 1:2,000 to 1:80,000 Preferably, 1:4,000 to 1:65,000, More preferably, 1:6,000 to 1:55,000. More preferably, 1:8,000 to 1:45,000, More specifically, 1:10,000 to 1:35,000 A food product or other product for oral intake containing the aforementioned thaumatin:the aforementioned sugar in a mass ratio.
  2. The product contains 2 to 12% by mass, preferably 3 to 10% by mass, more preferably 4 to 8% by mass of the sugar selected from the group consisting of sucrose, glucose, and fructose, based on the total mass of the product; and/or contains 1 to 13 ppm, preferably 3 ppm to 7 ppm of thaumatin per unit of the total mass of the product, wherein the thaumatin is at least one type of thaumatin selected from the group consisting of thaumatin I and thaumatin II. The product for oral intake according to claim 1.
  3. The product contains 2 to 12% by mass, preferably 3 to 10% by mass, more preferably 4 to 8% by mass of the sugar selected from the group consisting of sucrose, glucose, and fructose, relative to the total mass of the product; and contains 1 to 13 ppm, preferably 3 ppm to 7 ppm of thaumatin per unit of the total mass of the product, wherein the thaumatin is at least one type of thaumatin selected from the group consisting of thaumatin I and thaumatin II. The product for oral intake according to claim 1.
  4. The product contains at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II, and at least one sugar selected from the group consisting of sucrose, glucose, and fructose, in a mass ratio of thaumatin to sugar of 1:10,000 to 1:35,000. A food or other product for oral intake, comprising, in proportion to the total mass of the product, 4 to 8% by mass of a sugar selected from the group consisting of sucrose, glucose, and fructose, and further comprising 3 ppm to 7 ppm of thaumatin per unit of the total mass of the product, wherein the thaumatin is at least one type of thaumatin selected from the group consisting of thaumatin I and thaumatin II.
  5. An orally administered product comprising 1 to 13 ppm, preferably 3 to 7 ppm, of thaumatin per total mass of the product, and at least one sugar selected from the group consisting of sucrose, glucose, and fructose, wherein the thaumatin is at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II.
  6. The orally ingestible product according to claim 1 or 5, comprising 2 to 12% by mass, preferably 3 to 10% by mass, and more preferably 4 to 8% by mass of the sugar selected from the group consisting of sucrose, glucose, and fructose, based on the total mass of the product.
  7. The oral product according to any one of claims 1 to 6, wherein the at least one sugar is selected from the group consisting of glucose and fructose, and does not contain sucrose.
  8. An orally administered product according to any one of claims 1 to 7, comprising high-fructose corn syrup (HFCS) containing at least one sugar selected from the group consisting of glucose and fructose.
  9. The oral intake product according to claim 8, wherein the HFCS is HFCS-42, HFCS-55, HFCS-65, HFCS-70, or HFCS-90.
  10. The HFCS contains 22-25% by mass of water and 78-75% dissolved or dispersed solids based on the total mass of the HFCS. The product for oral intake according to claim 8 or 9, wherein the solid contains 15 to 92% by mass of fructose, 8 to 85% by mass of glucose, and 0 to 7% by mass of glucose oligosaccharides based on the total mass of the solid, and preferably the solid contains 40 to 65% by mass of fructose, 30 to 55% by mass of glucose, and 0 to 7% by mass of glucose oligosaccharides based on the total mass of the solid.
  11. It comprises at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II, and a sugar selected from the group consisting of glucose and fructose, and the sugar selected from the group consisting of glucose and fructose, 1:2,000 to 1:80,000 Preferably, 1:4,000 to 1:65,000, More preferably, 1:6,000 to 1:55,000. More preferably, 1:8,000 to 1:45,000, More specifically, 1:10,000 to 1:35,000 A food or other product for oral intake containing the aforementioned thaumatin in the mass ratio of the aforementioned sugar.
  12. The product for oral intake according to claim 11, comprising 2 to 12% by mass, preferably 3 to 10% by mass, more preferably 4 to 8% by mass of the sugar selected from the group consisting of glucose and fructose, based on the total mass of the product; and/or comprising 1 to 13 ppm, preferably 3 ppm to 7 ppm of thaumatin per total mass of the product, wherein the thaumatin is at least one type of thaumatin selected from the group consisting of thaumatin I and thaumatin II.
  13. The product for oral intake according to claim 11, comprising 2 to 12% by mass, preferably 3 to 10% by mass, more preferably 4 to 8% by mass of the sugar selected from the group consisting of glucose and fructose, based on the total mass of the product; and comprising 1 to 13 ppm, preferably 3 ppm to 7 ppm of thaumatin per total mass of the product, wherein the thaumatin is at least one type of thaumatin selected from the group consisting of thaumatin I and thaumatin II.
  14. The oral product according to any one of claims 1 to 13, comprising high-fructose corn syrup (HFCS) as the at least one sugar selected from the group consisting of glucose and fructose.
  15. A product for oral intake according to any one of claims 1 to 14, which is a beverage, beverage powder, soft drink, yogurt, jam, marmalade, syrup or other beverage concentrate, dessert, cake, biscuit, cookie, chocolate, candy, confectionery, sugar confectionery, chewing gum, custard, pudding, jelly, filling jelly, pastry, pie, hard candy, processed food, cereal, baked product, or pharmaceutical; wine or beer or other fermented or distilled beverage, potato-based snack, breakfast cereal, chewing gum, ice cream, cocoa and chocolate products, breath mint, sugar decoration or icing, coating or filling, fine bakery items, food additive, or table sweetener.
  16. A composition suitable for manufacturing orally administered products, comprising at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II, and at least one sugar selected from the group consisting of sucrose, glucose, and fructose.
  17. The composition according to claim 16, comprising at least one sugar selected from the group consisting of glucose and fructose, and not containing sucrose.
  18. A composition suitable for manufacturing orally administered products, comprising at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II, and high-fructose corn syrup (HFCS) containing at least one sugar selected from the group consisting of glucose and fructose.
  19. The composition according to any one of claims 16 to 18, comprising 1 to 13 ppm, preferably 3 ppm to 7 ppm, of the total mass of the composition, of at least one of the thaumatin.
  20. The above-mentioned at least one thaumatin and the above-mentioned at least one sugar, 1:2,000 to 1:80,000 Preferably, 1:4,000 to 1:65,000, More preferably, 1:6,000 to 1:55,000. More preferably, 1:8,000 to 1:45,000, More specifically, 1:10,000 to 1:35,000 The composition according to any one of claims 16 to 19, containing thaumatin in a mass ratio of thaumatin to sugar.

Description

Application for application of Article 30, Paragraph 2 of the Patent Law filed on July 6, 2020. Published on the websites "https://www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices&id=910&sort=GRN_No&order=DESC&startrow=1&type=basic&search=Nomad" and "https://www.fda.gov/media/139609/download". This invention relates to an orally ingestible product, such as a food, comprising thaumatin and at least one sugar selected from the group consisting of sucrose, glucose, and fructose. In the product, the sugar content can be reduced with little or no effect on sweetness and other flavor qualities. Furthermore, this invention relates to a composition suitable for producing an orally ingestible product, the composition comprising at least one thaumatin and at least one sugar selected from the group consisting of sucrose, glucose, and fructose. The use of such a composition as a sweetening composition or for reducing the calorie content of an orally ingestible product is provided. This invention also provides a method for reducing the sugar content in an orally ingestible product and a method for reducing the spiciness of high-fructose corn syrup in an orally ingestible product. Excessive consumption of sugary foods and beverages is a growing health problem for many people in developing and emerging countries. The resulting health problems are well-known and include increased vulnerability to cardiovascular disease and infectious diseases such as COVID-19, as well as associated risks. Recent trends in the food industry have led producers to reduce the sugar and/or high-fructose corn syrup (HFCS) content, and therefore the calorie content. However, the taste and quality of a product should not be altered too drastically so as not to impair consumer perception of the product. Since sugar content has eugenic effects not only on taste, particularly the perception of sweetness, but also on other sensory characteristics such as texture, viscosity, and chewiness, as well as on preservation against microbial attack, reducing the sugar content of sugar-containing products, especially those with high sugar content, without impairing other desirable characteristics of the product is not an easy task. Therefore, an object of the present invention is to provide orally ingestible products and compositions, such as foods, in which the sugar content is reduced. Another object of the present invention is to provide orally ingestible products and compositions in which the sugar content is reduced and which achieve the same or very similar taste qualities as conventional products in terms of sweetness, overall taste and aftertaste. A further object is to provide sweetening compositions for orally ingestible products, and methods for reducing the sugar content in orally ingestible products with little to no change in taste qualities such as sweetness, overall taste and aftertaste. These objectives are achieved by: 1) At least one thaumatin selected from the group consisting of thaumatin I and thaumatin II, and at least one sugar selected from the group consisting of sucrose, glucose, and fructose, 1:2,000 to 1:80,000 Preferably, 1:4,000 to 1:65,000, More preferably, 1:6,000 to 1:55,000. More specifically, 1:8,000 to 1:45,000, More specifically, 1:10,000 to 1:35,000 A product for oral intake, such as a food, containing the aforementioned thaumatin and the aforementioned sugar in a mass ratio. 2) A product for oral intake comprising 1 to 13 ppm, preferably 3 ppm to 7 ppm, of thaumatin and at least one sugar selected from the group consisting of sucrose, glucose, and fructose, wherein the thaumatin is at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II. 3) The product for oral intake according to item 1 or 2, comprising 2 to 12% by mass, preferably 3 to 10% by mass, and more preferably 4 to 8% by mass of the sugar selected from the group consisting of sucrose, glucose, and fructose, based on the total mass of the product. 4) The product for oral intake according to any one of claims 1 to 3, wherein at least one sugar is selected from the group consisting of glucose and fructose, and does not contain sucrose. 5) A product for oral intake according to any one of claims 1 to 4, comprising high-fructose corn syrup (HFCS) containing at least one sugar selected from the group consisting of glucose and fructose. 6) The oral product according to item 5, wherein the HFCS is HFCS-42, HFCS-55, HFCS-65, HFCS-70, or HFCS-90. 7) Containing 22 to 25% by mass of water and 78% to 75% dissolved or dispersed solids per total mass of HFCS, The product for oral intake according to claim 5 or 6, wherein the solid contains 15 to 92% by mass of fructose, 8 to 85% by mass of glucose, and 0 to 7% by mass of glucose oligosaccharides based on the total mass of the solid, and preferably the solid contains 40 to 65% by mass of fructose, 30 to 55% by mass of glucose, and 0 to 7% by mass of glucose oligosaccharides based on the tot